Mississippi lawmakers are considering House Bill 602 and Senate Bill 2014, both designed to ensure consumers know whether ...
The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...
No. 4 Alabama enters a matchup against No. 14 Mississippi State as winners of five consecutive road games. The teams match up Wednesday for the first time this season.
Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated ...
The Food & Drug Administration (FDA), has quietly taken down their guidance detailing diversity action plans for clinical ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.
GlobalData on MSN6d
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis casesThe FDA reported that six patients died after being injected with Teva’s Copaxone or Sandoz’s Glatopa. The US Food and Drug ...
The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer ...
The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...
The Food & Drug Administration (FDA), has quietly taken down their guidance detailing diversity action plans for clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback